Michael J Liptay
Overview
Explore the profile of Michael J Liptay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
687
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan A, Shah S, Naeem W, Basu S, Alex G, Geissen N, et al.
J Am Coll Surg
. 2025 Feb;
PMID: 39964073
Introduction: We hypothesize that reduction in skeletal muscle volume between the time of surgery and the first postoperative surveillance CT scan is associated with recurrence in resected early-stage NSCLC patients....
2.
Khan A, Shah S, Basu S, Alex G, Liptay M, Geissen N, et al.
J Am Coll Surg
. 2025 Jan;
PMID: 39813202
Background: It has been proposed that more aggressive tumors trigger a stronger inflammatory response than less aggressive types. We hypothesize that systemic immune inflammatory index (SII) is associated with occult...
3.
Stephan J, Mehta P, Zepeda D, Uppal M, Basu S, Liptay M, et al.
Ann Thorac Surg Short Rep
. 2025 Jan;
1(4):558-561.
PMID: 39790682
Background: The objective of this study was to investigate whether lung cancer screening low-dose computed tomography (LDCT) can be used to identify features associated with increased risk of hospitalization during...
4.
Shah S, Kim S, Khan A, Krishnan V, Lally A, Shah P, et al.
Lung
. 2024 Sep;
202(5):657.
PMID: 39285000
No abstract available.
5.
Shah S, Kim S, Khan A, Krishnan V, Lally A, Shah P, et al.
Lung
. 2024 Aug;
202(5):649-655.
PMID: 39164595
Purpose: Firefighting is known to be carcinogenic to humans. However, current lung cancer screening guidelines do not account for occupational exposure. We hypothesize that firefighting is an independent risk factor...
6.
Shah S, Krishnan V, Khan A, Fass L, Chaudhry T, Seder C, et al.
Ann Surg Oncol
. 2024 Jul;
31(10):6673-6679.
PMID: 38987373
Purpose: To perform a systematic review of clinical trials examining non-small cell lung cancer (NSCLC) to better understand the equity afforded to women in the study of lung cancer. Methods:...
7.
Chaudhry T, Krishnan V, Donaldson A, Palmisano Z, Basu S, Geissen N, et al.
JTCVS Open
. 2024 Jan;
16:948-959.
PMID: 38204712
Background: Conditional survival (CS) analyses provide an estimate of survival accounting for years already survived after treatment. We aim to evaluate the difference between actuarial and conditional survival in patients...
8.
Auger C, Moudgalya H, Neely M, Stephan J, Tarhoni I, Gerard D, et al.
Cancers (Basel)
. 2023 May;
15(8).
PMID: 37190187
Due to poor compliance and uptake of LDCT screening among high-risk populations, lung cancer is often diagnosed in advanced stages where treatment is rarely curative. Based upon the American College...
9.
Wakefield C, Lund N, Coughlin J, Karush J, Geissen N, Alex G, et al.
J Thorac Dis
. 2022 Dec;
14(11):4256-4265.
PMID: 36524067
Background: Sarcopenia, as measured at the 3rd lumbar (L3) level, has been shown to prognosticate survival in cancer patients. However, many patients with early-stage non-small cell lung cancer (NSCLC) do...
10.
Karush J, Alex G, Geissen N, Wakefield C, Basu S, Liptay M, et al.
Ann Thorac Surg
. 2022 Aug;
115(3):687-692.
PMID: 35921862
Background: Anticipating the need for non-home discharge (NHD) enables improved patient counseling and expedites placement, potentially reducing length of stay and hospital readmission. The objective of this study was to...